메뉴 건너뛰기




Volumn 38, Issue 6, 1997, Pages 907-916

19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5- benzylacyclouridine

Author keywords

5 benzylacyclouridine; 5 fluorouracil; Tumor metabolism monitoring

Indexed keywords

AMINO ACIDS; HISTOLOGY; MAMMALS; METABOLISM; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORYLATION;

EID: 0030608756     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380609     Document Type: Article
Times cited : (21)

References (37)
  • 1
    • 0342952508 scopus 로고    scopus 로고
    • Pyrimidine and purine antimetabolites
    • (J. F. Holland, R. C. Bast, D. L. Morton, E. Frei III, D. W. Kufe, R.R. Weichselbaum, Eds.), 4th ed., Williams & Wilkins, Baltimore
    • G. Pizzorno, Y. C. Cheng, R. E. Handschumacher, Pyrimidine and purine antimetabolites, in "Cancer Medicine" (J. F. Holland, R. C. Bast, D. L. Morton, E. Frei III, D. W. Kufe, R.R. Weichselbaum, Eds.), 4th ed., pp. 923-948, Williams & Wilkins, Baltimore, 1997.
    • (1997) Cancer Medicine , pp. 923-948
    • Pizzorno, G.1    Cheng, Y.C.2    Handschumacher, R.E.3
  • 2
    • 0005595182 scopus 로고
    • Biochemical modulation: Perspectives and objectives
    • Academic Press, New York
    • D. S. Martin, Biochemical modulation: perspectives and objectives, in "New Avenues in Developmental Cancer Chemotherapy," Academic Press, New York, 1987.
    • (1987) New Avenues in Developmental Cancer Chemotherapy
    • Martin, D.S.1
  • 3
    • 0025815823 scopus 로고
    • Clinical relevance of biochemical modulation of 5-fluorouracil
    • G. J. Peters, C. J. van Groeningen, Clinical relevance of biochemical modulation of 5-fluorouracil. Ann. Oncol. 2, 469-480 (1991).
    • (1991) Ann. Oncol. , vol.2 , pp. 469-480
    • Peters, G.J.1    Van Groeningen, C.J.2
  • 4
    • 0021247086 scopus 로고
    • Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: Attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate
    • N. E. Kemeny, T. Ahmed, R. A. Michaelson, Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate. J. Clin. Oncol. 2, 311-315 (1984).
    • (1984) J. Clin. Oncol. , vol.2 , pp. 311-315
    • Kemeny, N.E.1    Ahmed, T.2    Michaelson, R.A.3
  • 7
    • 0025261244 scopus 로고
    • Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy
    • J. H. Doroshow, P. Multhauf, L. Leong, K. Margolin, T. Litchfield, S. Akman, B. Carr, M. Bertrand, D. Goldberg, D. Blayney, O. Odujinrin, R. Delap, J. Shuster, E. Newman, Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J. Clin. Oncol. 8, 491-501 (1990).
    • (1990) J. Clin. Oncol. , vol.8 , pp. 491-501
    • Doroshow, J.H.1    Multhauf, P.2    Leong, L.3    Margolin, K.4    Litchfield, T.5    Akman, S.6    Carr, B.7    Bertrand, M.8    Goldberg, D.9    Blayney, D.10    Odujinrin, O.11    Delap, R.12    Shuster, J.13    Newman, E.14
  • 8
    • 0020621335 scopus 로고
    • Therapeutic utility of utilizing low doses of N-(phosphonoacetyl)-L-aspartic acid in combination with 5-fluorouracil: A murine study with clinical relevance
    • D. S. Martin, R. L. Stolfi, R. C. Sawyer, S. Spiegelman, E. S. Casper, C. W. Young, Therapeutic utility of utilizing low doses of N-(phosphonoacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance. Cancer Res. 43, 2317-2311 (1983).
    • (1983) Cancer Res. , vol.43 , pp. 2317-12311
    • Martin, D.S.1    Stolfi, R.L.2    Sawyer, R.C.3    Spiegelman, S.4    Casper, E.S.5    Young, C.W.6
  • 9
    • 0023917467 scopus 로고
    • A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonoacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers
    • B, Ardalan, G. Singh, H. Silberman, A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonoacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers. J. Clin. Oncol. 6, 1053-1058 (1988).
    • (1988) J. Clin. Oncol. , vol.6 , pp. 1053-1058
    • Ardalan, B.1    Singh, G.2    Silberman, H.3
  • 10
    • 0024992069 scopus 로고
    • Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer
    • P. J. O'Dwyer, A. R. Paul, J. Walczak, L. M. Weiner, S. Litwin, R. L. Comis, Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. J. Clin. Oncol. 8, 1497-1503 (1990).
    • (1990) J. Clin. Oncol. , vol.8 , pp. 1497-1503
    • O'Dwyer, P.J.1    Paul, A.R.2    Walczak, J.3    Weiner, L.M.4    Litwin, S.5    Comis, R.L.6
  • 11
    • 0026741667 scopus 로고
    • Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools
    • G. Pizzorno, R. A. Wiegand, S. K. Lentz, R. E. Handschumacher, Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools. Cancer Res. 52, 1660-1665 (1992).
    • (1992) Cancer Res. , vol.52 , pp. 1660-1665
    • Pizzorno, G.1    Wiegand, R.A.2    Lentz, S.K.3    Handschumacher, R.E.4
  • 14
    • 0023187085 scopus 로고
    • Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile
    • D. Heggie, J.-P. Sommadossi, D. S. Cross, W. J. Huster, R. Diasio, Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile. Cancer Res. 47, 2203-2206 (1987).
    • (1987) Cancer Res. , vol.47 , pp. 2203-2206
    • Heggie, D.1    Sommadossi, J.-P.2    Cross, D.S.3    Huster, W.J.4    Diasio, R.5
  • 15
    • 0026701936 scopus 로고
    • Mechanismbased inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil
    • D. J. T. Porter, W. G. Chestnut, B. M. Merrill, T. Spector, Mechanismbased inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. J. Biol. Chem. 267, 5236-5242 (1992).
    • (1992) J. Biol. Chem. , vol.267 , pp. 5236-5242
    • Porter, D.J.T.1    Chestnut, W.G.2    Merrill, B.M.3    Spector, T.4
  • 16
    • 0028281781 scopus 로고
    • 5-Ethynyluracil (776C85): Modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing colorectal carcinoma
    • S. Cao, Y. M. Rustum, T. Spector, 5-Ethynyluracil (776C85): modulation of 5-fluorouracil efficacy and therapeutic index in rats bearing colorectal carcinoma. Cancer Res. 54, 1507-1510 (1994).
    • (1994) Cancer Res. , vol.54 , pp. 1507-1510
    • Cao, S.1    Rustum, Y.M.2    Spector, T.3
  • 17
    • 0020037313 scopus 로고
    • 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase
    • J. G. Niedzwicki, S. H. Chu, M. H. el Kouni, E. C. Rowe, S, Cha, 5-Benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. Biochem. Pharmacol. 31, 1857-1861 (1982).
    • (1982) Biochem. Pharmacol. , vol.31 , pp. 1857-1861
    • Niedzwicki, J.G.1    Chu, S.H.2    El Kouni, M.H.3    Rowe, E.C.4    Cha, S.5
  • 18
    • 0022379204 scopus 로고
    • Tissue specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine
    • J. W. Darnowski, R. E. Handschumacher, Tissue specific enhancement of uridine utilization and 5-fluorouracil therapy in mice by benzylacyclouridine. Cancer Res. 45, 5364-5368 (1985).
    • (1985) Cancer Res. , vol.45 , pp. 5364-5368
    • Darnowski, J.W.1    Handschumacher, R.E.2
  • 19
    • 0024375273 scopus 로고
    • Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine
    • D. S. Martin, R.L Stolfi, R. C. Sawyer, Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine. Cancer Chemother. Pharmacol. 24, 9-14 (1989).
    • (1989) Cancer Chemother. Pharmacol. , vol.24 , pp. 9-14
    • Martin, D.S.1    Stolfi, R.L.2    Sawyer, R.C.3
  • 20
    • 0020531847 scopus 로고
    • Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver
    • A. Monks, O. Ayers. R. L. Cysyk, Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver. Biochem. Pharmacol. 32, 2003-2009 (1983).
    • (1983) Biochem. Pharmacol. , vol.32 , pp. 2003-2009
    • Monks, A.1    Ayers, O.2    Cysyk, R.L.3
  • 21
    • 0025921621 scopus 로고
    • F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver
    • P. E. Sijens, Y. M. Huang, N. J. Baldwin, T. C. Ng, F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Cancer Res. 51, 1384-1390 (1991).
    • (1991) Cancer Res. , vol.51 , pp. 1384-1390
    • Sijens, P.E.1    Huang, Y.M.2    Baldwin, N.J.3    Ng, T.C.4
  • 22
    • 0026360179 scopus 로고
    • In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using F nuclear magnetic resonance spectroscopy
    • A. El-Tahtawy, W. Wolf, In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-fluorouracil, using F nuclear magnetic resonance spectroscopy. Cancer Res. 51, 5806-5812 (1991).
    • (1991) Cancer Res. , vol.51 , pp. 5806-5812
    • El-Tahtawy, A.1    Wolf, W.2
  • 23
    • 0022638354 scopus 로고
    • Tissue uridine pools: Evidence in vivo of a concentrative mechanism for uridine uptake
    • J. W. Darnowski, R. E. Handschumacher, Tissue uridine pools: evidence in vivo of a concentrative mechanism for uridine uptake. Cancer Res. 46, 3490-3494 (1986).
    • (1986) Cancer Res. , vol.46 , pp. 3490-3494
    • Darnowski, J.W.1    Handschumacher, R.E.2
  • 25
    • 0018390860 scopus 로고
    • Comparison of liquid-and gas-liquid chromatographic assays of 5-fluorouracil in plasma
    • N. Christophidis, G. Mihaly, M. Vadja, W. Louis, Comparison of liquid-and gas-liquid chromatographic assays of 5-fluorouracil in plasma. Clin. Chem. 25, 83-87 (1979).
    • (1979) Clin. Chem. , vol.25 , pp. 83-87
    • Christophidis, N.1    Mihaly, G.2    Vadja, M.3    Louis, W.4
  • 26
    • 0024419144 scopus 로고
    • Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS
    • P. M. McSheehy, M. J. Prior, J. R. Griffiths, Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS. Br. J. Cancer. 60, 303-309 (1989).
    • (1989) Br. J. Cancer. , vol.60 , pp. 303-309
    • McSheehy, P.M.1    Prior, M.J.2    Griffiths, J.R.3
  • 27
    • 0025887689 scopus 로고
    • Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy
    • P. E. Sijens, N. J. Baldwin, T. C. Ng, Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy Magn. Reson. Med. 19, 373-385 (1991).
    • (1991) Magn. Reson. Med. , vol.19 , pp. 373-385
    • Sijens, P.E.1    Baldwin, N.J.2    Ng, T.C.3
  • 28
    • 0026603804 scopus 로고
    • Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: A 19F-MRS study in vivo
    • P. M. J. McSheehy, M. J. W. Prior, J.R Griffiths, Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo. Br. J. Cancer 65, 369-375 (1992).
    • (1992) Br. J. Cancer , vol.65 , pp. 369-375
    • McSheehy, P.M.J.1    Prior, M.J.W.2    Griffiths, J.R.3
  • 30
    • 0023942798 scopus 로고
    • Benzylacyclouridine pharmacokinetics, metabolism and biochemical effect in mice
    • J. W. Darnowski, R. E. Handschumacher, Benzylacyclouridine pharmacokinetics, metabolism and biochemical effect in mice. Biochem. Pharmacol. 37, 2613-2819 (1988).
    • (1988) Biochem. Pharmacol. , vol.37 , pp. 2613-2819
    • Darnowski, J.W.1    Handschumacher, R.E.2
  • 31
    • 0024599491 scopus 로고
    • Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liver
    • F. N. M. Naguib, M. H. el Kouni, S. M. Cha, Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liver. Biochem. Pharmacol. 38, 1471-1480 (1989).
    • (1989) Biochem. Pharmacol. , vol.38 , pp. 1471-1480
    • Naguib, F.N.M.1    El Kouni, M.H.2    Cha, S.M.3
  • 32
    • 0023909330 scopus 로고
    • Determinants of tumor blood flow: A review
    • R. K. Jain, Determinants of tumor blood flow: a review. Cancer Res. 48, 2641-2658 (1988).
    • (1988) Cancer Res. , vol.48 , pp. 2641-2658
    • Jain, R.K.1
  • 33
    • 0001850880 scopus 로고
    • Physiological resistance to the treatment of solid tumors
    • (B. A. Teicher, Ed.), M. Dekker, New York
    • R.K Jain, Physiological resistance to the treatment of solid tumors, in "Drug Resistance in Oncology" (B. A. Teicher, Ed.), pp. 87-105, M. Dekker, New York, 1993.
    • (1993) Drug Resistance in Oncology , pp. 87-105
    • Jain, R.K.1
  • 34
    • 0023481357 scopus 로고
    • Transport of molecules across tumor vasculature
    • R. K. Jain, Transport of molecules across tumor vasculature. Cancer Metastasis Rev. 6, 559-593 (1987).
    • (1987) Cancer Metastasis Rev. , vol.6 , pp. 559-593
    • Jain, R.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.